115 related articles for article (PubMed ID: 4614247)
1. A double-blind study of metoclopramide in symptomatic peptic oesophagitis.
Venables CW; Bell D; Eccleston D
Postgrad Med J; 1973 Jul; 49 Suppl 4():suppl 4:73-7. PubMed ID: 4614247
[No Abstract] [Full Text] [Related]
2. Effect of oral metoclopramide on gastroesophageal reflux in the post-cibal state.
Behar J; Biancani P
Gastroenterology; 1976 Mar; 70(3):331-5. PubMed ID: 765184
[TBL] [Abstract][Full Text] [Related]
3. A controlled trail of metoclopramide in reflux oesophagitis.
Paull A; Kerr A; Grant AK
Med J Aust; 1974 Oct; 2(17):627-9. PubMed ID: 4614025
[No Abstract] [Full Text] [Related]
4. Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a double-blind trial.
McCallum RW; Fink SM; Winnan GR; Avella J; Callachan C
Am J Gastroenterol; 1984 Mar; 79(3):165-72. PubMed ID: 6367434
[TBL] [Abstract][Full Text] [Related]
5. Prevention of meal-induced heartburn and regurgitation with metoclopramide in patients with gastroesophageal reflux.
Fuchs B; Bartolomeo RS
Clin Ther; 1982; 5(2):179-85. PubMed ID: 6760968
[TBL] [Abstract][Full Text] [Related]
6. [Effect of metoclopramide (Cerucal) on postprandial gastroesophageal reflux].
Pflücke F
Dtsch Z Verdau Stoffwechselkr; 1981; 41(1):13-7. PubMed ID: 7014183
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of metoclopramide in symptomatic gastroesophageal reflux.
McCallum RW; Ippoliti AF; Cooney C; Sturdevant RA
N Engl J Med; 1977 Feb; 296(7):354-7. PubMed ID: 319356
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of metoclopramide and bethanechol on lower esophageal sphincter pressure in reflux patients.
McCallum RW; Kline MM; Curry N; Sturdevant RA
Gastroenterology; 1975 May; 68(5 Pt 1):1114-8. PubMed ID: 1092585
[TBL] [Abstract][Full Text] [Related]
9. Effect of single and repeated doses of metoclopramide on the mechanisms of gastroesophageal reflux.
Durazo FA; Valenzuela JE
Am J Gastroenterol; 1993 Oct; 88(10):1657-62. PubMed ID: 8213706
[TBL] [Abstract][Full Text] [Related]
10. Flatulent dyspepsia.
Johnson AG
Postgrad Med J; 1973 Jul; 49 Suppl 4():suppl 4:104-7. PubMed ID: 4614242
[No Abstract] [Full Text] [Related]
11. Esophageal acid contact time and heartburn in acute treatment with ranitidine and metoclopramide.
Orr WC; Finn A; Wilson T; Russell J
Am J Gastroenterol; 1990 Jun; 85(6):697-700. PubMed ID: 2191595
[TBL] [Abstract][Full Text] [Related]
12. [Cinitapride in the treatment of gastroesophageal reflux. Comparative study with metoclopramide and placebo].
Surós A; Adell F; De Novoa V; Castellarnau J; Diosdado D; Carrasquer J; Merelló J
Rev Med Univ Navarra; 1992; 37(1):18-23. PubMed ID: 1626164
[No Abstract] [Full Text] [Related]
13. Domperidone, metoclopramide, and placebo. All give symptomatic improvement in gastroesophageal reflux.
Maddern GJ; Kiroff GK; Leppard PI; Jamieson GG
J Clin Gastroenterol; 1986 Apr; 8(2):135-40. PubMed ID: 3745846
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
[TBL] [Abstract][Full Text] [Related]
15. The effect of oral and intravenous metoclopramide on human lower esophageal sphincter pressure.
Cohen S; Morris DW; Schoen HJ; DiMarino AJ
Gastroenterology; 1976 Apr; 70(4):484-7. PubMed ID: 767194
[TBL] [Abstract][Full Text] [Related]
16. Heartburn severity does not predict disease severity in patients with erosive esophagitis.
Fennerty MB; Johnson DA
MedGenMed; 2006 Apr; 8(2):6. PubMed ID: 16926745
[TBL] [Abstract][Full Text] [Related]
17. [Effect of metoclopramide on complaints of reflux disease].
Pflücke F
Z Gesamte Inn Med; 1981 Feb; 36(4):122-4. PubMed ID: 7013303
[TBL] [Abstract][Full Text] [Related]
18. Cimetidine, metoclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux.
Bright-Asare P; El-Bassoussi M
J Clin Gastroenterol; 1980 Jun; 2(2):149-56. PubMed ID: 7002998
[No Abstract] [Full Text] [Related]
19. Nizatidine versus placebo in gastro-oesophageal reflux disease: a 6-week, multicentre, randomised, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group.
Cloud ML; Offen WW
Br J Clin Pract Suppl; 1994 Nov; 76():11-9. PubMed ID: 7794700
[TBL] [Abstract][Full Text] [Related]
20. Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis.
Guslandi M; Testoni PA; Passaretti S; Masci E; Ballarin E; Comin U; Marchi R; Ronchi G; Tittobello A
Hepatogastroenterology; 1983 Jun; 30(3):96-8. PubMed ID: 6309637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
